Vonoprazan non‐inferior to lansoprazole in treating duodenal ulcer and eradicating <scp> <i>Helicobacter pylori</i> </scp> in Asian patients-Reference-Cited by-全球学者库

Vonoprazan non‐inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients

Published:2022-05-05 Issue:7 Volume:37 Page:1275-1283
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J of Gastro and Hepatol

Author:

Hou Xiaohua¹^ORCID,Meng Fandong²^ORCID,Wang Jiangbin³,Sha Weihong⁴^ORCID,Chiu Cheng‐Tang⁵⁶,Chung Woo Chul⁷,Gu Liqun⁸,Kudou Kentarou⁹^ORCID,Chong Chui Fung¹⁰,Zhang Shutian²^ORCID

Affiliation:

1. Division of Gastroenterology Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China

2. Department of Gastroenterology Beijing Friendship Hospital, Capital Medical University Beijing China

3. China‐Japan Union Hospital, Jilin University Changchun China

4. Department of Gastroenterology and Hepatology Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences) Guangdong China

5. Department of Gastroenterology and Hepatology Chang Gung Memorial Hospital, Linkou Medical Center Taoyuan Taiwan

6. Chang Gung University, College of Medicine Taoyuan Taiwan

7. St Vincent's Hospital, College of Medicine, The Catholic University of Korea Seoul South Korea

8. Takeda Development Center Asia Shanghai China

9. Takeda Pharmaceutical Company Limited Osaka Japan

10. Takeda Development Center Asia Singapore

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15837

Reference31 articles.

1. Chronic unexplained nausea in adults: Prevalence, impact on quality of life, and underlying organic diseases in a cohort of 5096 subjects comprehensively investigated

2. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database

3. Seasonal Variations and Trends in Hospitalization for Peptic Ulcer Disease in the United States: A 12-Year Analysis of the Nationwide Inpatient Sample

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clarifying varied Helicobacter pylori eradication therapies: A comprehensive review;Helicobacter;2024-01

2. Vonoprazan and amoxicillin dual therapy for 14 days as the first‐line treatment of Helicobacter pylori infection: A non‐inferiority, randomized clinical trial;Helicobacter;2024-01

3. Efficacy and Safety of Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors as Helicobacter pylori Eradication Therapy: A Meta-Analysis of Randomized Clinical Trials;Cureus;2023-11-07

4. Engineered dendritic architecture loaded with proton pump inhibitor for antibacterial therapy: Newer solution for gastric upset;Journal of Drug Delivery Science and Technology;2023-11

5. Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study;Journal of Gastroenterology;2023-10-01